Researchers say cell manipulation could lead to better drug delivery

Mar 11, 2011

(PhysOrg.com) -- UT Arlington researchers are using focused laser beams to manipulate cells that lead drug-carrying nanoparticles that deliver medicine to cancer cells that need it.

Samarendra Mohanty, assistant professor of physics, and Kytai Nguyen, associate professor of bioengineering, are part of the collaborative research effort in The University of Texas at Arlington’s Biophysics and Physiology Lab.

Those focused laser beams are called optical tweezers and are used in cell manipulation.

The team has tested the process at the microscopic level using human cells and will present the research at the March meeting of American Physical Society in Dallas.

Nguyen said results from this research would help investigators design that have more therapeutic benefits while reducing severe side effects often seen in chemotherapy.

“A focused laser holds the cell. We then use a force against the cell to measure the single cell’s elasticity,” Mohanty said. Elasticity measures how much that cell can stretch. “A cancer cell is normally more brittle, so those can be identified. A nanoparticle carrying a drug is then introduced with the optical tweezers.”

Nguyen said how these nanoparticles interact with the cell gives the researchers valuable information about the cell.

“We can coat them with an antibody that is bound to diseased cells and deliver drugs to only these cells to treat illnesses,” Nguyen said.

Mohanty also is working in the field of optogenetics, an emerging field using low-power light to stimulate neuronal cells. Mohanty said those specific genetically targeted neurons are stimulated with a micro LED (light emitting diode).

He said there has been some success using optogenetics to treat retinitis pigmentosa, an eye disease in which there is loss of vision due to degeneration of photoreceptors in retina.

Explore further: Physicists create new nanoparticle for cancer therapy

Provided by University of Texas at Arlington

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Using Gold Nanoparticles to Hit Cancer Where It Hurts

Feb 15, 2010

(PhysOrg.com) -- Taking gold nanoparticles to the cancer cell and hitting them with a laser has been shown to be a promising tool in fighting cancer, but what about cancers that occur in places where a laser light can’t ...

Two-In-One Punch Knocks Out Drug Resistant Cancer Cells

Nov 04, 2009

(PhysOrg.com) -- Cancer cells, like bacteria, can develop resistance to drug therapy, leading to relapse of disease. One approach showing promise in overcoming multidrug resistance in tumors is to combine two different anticancer ...

Nano-Vehicle acts as cluster bomb for tumors

Sep 18, 2010

Chemotherapy, while an effective cancer treatment, also brings debilitating side effects such as nausea, liver toxicity, and a battered immune system. Now, a new way to deliver this life-saving therapy to cancer patients ...

'Nanobubbles' kill cancer cells

Feb 04, 2010

(PhysOrg.com) -- Using lasers and nanoparticles, scientists at Rice University have discovered a new technique for singling out individual diseased cells and destroying them with tiny explosions. The scientists used lasers ...

Recommended for you

Physicists create new nanoparticle for cancer therapy

18 hours ago

A University of Texas at Arlington physicist working to create a luminescent nanoparticle to use in security-related radiation detection may have instead happened upon an advance in photodynamic cancer therapy.

User comments : 0

More news stories

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

'Chief Yahoo' David Filo returns to board

Yahoo announced the nomination of three new board members, including company co-founder David Filo, who earned the nickname and formal job title of "Chief Yahoo."